Related Experiment Video
Updated: Sep 22, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Models of head and neck squamous cell carcinoma using bioengineering approaches
Anton P Bonartsev1, Bo Lei2, Margarita S Kholina1
1Faculty of Biology, M.V. Lomonosov Moscow State University, Leninskie Gory 1-12, Moscow 119234, Russia.
Bioengineering offers promising models for head and neck squamous cell carcinoma (HNSCC) research, aiding in the development of new anticancer drugs and diagnostics. These advanced models improve understanding and treatment of this aggressive cancer.
Area of Science:
- Oncology
- Bioengineering
- Translational Medicine
Background:
- Head and neck squamous cell carcinoma (HNSCC) is an aggressive cancer known for early metastasis and rapid progression.
- Developing effective anticancer drugs and diagnostics requires accurate experimental models.
Purpose of the Study:
- To review current and emerging bioengineering-based HNSCC tumor models.
- To explore future directions for improved HNSCC experimental modeling.
Main Methods:
- Conventional methods include 2D cell cultures and in vivo animal models.
- Bioengineering techniques encompass genetic engineering, exposure models (ethanol/tobacco), spheroids, hydrogel and scaffold cultures, microfluidics, and co-culture systems (bone-tumor niche, cancer-normal cells, cancer-bacteria).
Main Results:
- A variety of bioengineering approaches exist for modeling HNSCC.
- These models offer enhanced relevance compared to conventional methods.
Conclusions:
- An integrated system of HNSCC models holds potential for advancing diagnosis, prevention, and treatment.
- Bioengineering innovations are crucial for future HNSCC research and therapeutic development.
More Related Videos
12:03Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019